The role of CYP2C19 gene polymorphisms on antiplatelet activity of clopidogrel among Arabs: systematic review and meta-analysis

Abdullah N. Alkattan, Nashwa M. Radwan, Nagla E. Mahmoud, Amjad F. Alfaleh, Amal Alfaifi, Khaled I. Alabdulkareem
doi: https://doi.org/10.1101/2022.02.01.22270244

Article Information

doi 
https://doi.org/10.1101/2022.02.01.22270244
History 
  • February 2, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Abdullah N. Alkattan1,*,
  2. Nashwa M. Radwan2,3,
  3. Nagla E. Mahmoud3,
  4. Amjad F. Alfaleh1,
  5. Amal Alfaifi3 and
  6. Khaled I. Alabdulkareem4
  1. 1Department of Research and Development, General Directorate of School Health, Ministry of Health, Riyadh, Saudi Arabia
  2. 2Department of Public Health and Community Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
  3. 3Department of Research, Assisting Deputyship for Primary Health Care, Ministry of Health, Riyadh, Saudi Arabia
  4. 4Department of Family Medicine, College of Medicine, Al-Imam Mohammad Bin Saud Islamic University, Riyadh, Saudi Arabia
  1. ↵*Correspondence to Abdullah Alkattan, abdullahalkattan{at}gmail.com
Back to top
Posted February 02, 2022.
Download PDF
Data/Code
Email
The role of CYP2C19 gene polymorphisms on antiplatelet activity of clopidogrel among Arabs: systematic review and meta-analysis
Abdullah N. Alkattan, Nashwa M. Radwan, Nagla E. Mahmoud, Amjad F. Alfaleh, Amal Alfaifi, Khaled I. Alabdulkareem
medRxiv 2022.02.01.22270244; doi: https://doi.org/10.1101/2022.02.01.22270244
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area